Ask any editor from the "good old days" of medical journals, ie, 20+
years ago,
about content vs ad copy and the discussion invariably turns to
supplements.
Once upon a time, the standards for supplement copy were the same as those
for the articles in the "regular" journal issues. This practice was
abandoned at
many journals when the journal salesfolk started running the show.
The result? Supplements became considered little better than birdcage
liners.
Some journals refused to allow supplements to be listed as legitimate
references.
The pendulum swung back to the point where many journals have
ferocious
standards for who is paying for a supplement vs who is
reviewing/developing
the copy and content.
It takes a powerful editorial group, and a marketing group that
understands
when to stop, to make sure that appropriate divisions are maintained.
Competing interests:
None declared